Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Explore US market cap tilt retirement funds to adjust exposure. The intro covers when tilting helps and how to implement a balanced approach.
28,282 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Oil prices jump again, fueling fears of broader economic stress as supply constraints and demand resilience push benc...
Shark Tank’s Kevin O’Leary argues that the ability to execute trumps workplace location as firms accelerate return-to...
Bitcoin trades near the mid-$60,000s after testing $70,000 earlier this week. Analysts say long-term holder activity ...
tesla’s optimus robot seriously becomes the focal point for investors debating TSLA stock as the company retools prod...
Nebius’s stock surges latest after the company lands a Meta partnership valued at up to $27 billion, building on a re...
Adobe is a powerhouse of creativity and marketing tech, but its stock has faced AI-driven noise. This guide breaks do...
Tesla's stock has traded with unusual calm as the company advances robotaxis and semiconductor initiatives. Early pil...
XRP surged to $1.60 on the regulatory milestone, then faded as macro headwinds and rising yields pressured all risk a...
Robinhood enters 2026 with expanded features and crypto access, while scrutiny tightens around fees and security. Thi...
Century 21 Chief Executive Mike Miedler says recruiting more Latino agents is crucial to serving the majority of futu...
Disney reports stronger-than-expected Q2 2026 results, lifting the stock 8% in early trading as streaming and parks r...